Digital therapeutics (DTx) deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs to prevent, manage, or treat a medical disorder or disease. They are used independently or in concert with medications, devices, or other therapies to optimize patient care and health outcomes.
Asthma and COPD
Target patient population:
Patients with persistent asthma and patients with Stage II-IV COPD.
What to expect:
Consistent levels of high medication adherence, consistent improvement in disease control, and reductions in Emergency Department visits and hospitalizations.
Indications for use:
Propeller’s digital platform helps asthma and COPD patients and their healthcare providers record and monitor medication usage, review symptoms, and receive personalized information about their disease management and its impact.
When used under the care of a physician with a compatible inhaled medication, the system can be used to reduce the frequency of respiratory health symptoms and exacerbations by increasing adherence through the use of feedback such as reminders and notifications, and self-management education.
Research has demonstrated that Propeller increases medication adherence by up to 58%, reduces rescue inhaler use by up to 78%, and reduces asthma- and COPD-related ED visits and hospitalizations by up to 57% and 35% respectively.
Patients use Propeller by attaching a sensor to their existing inhaler. The sensor tracks medication usage and location data and sends that information to an app on the patient’s smartphone. Propeller builds a personalized profile including symptom triggers and disease management tips to help them self-manage their disease. It also provides medication adherence reminders, air quality forecasts, in-app medication refills, shareable progress reports, and a lost-inhaler locator.
Risks & warnings:
This sensor is not meant to communicate emergencies. Sensor information can be delayed, and your care team may not be aware of your condition. If your sensor interferes in any way with use of your inhaler, remove your sensor. Do not put the sensor underwater. Never delay using your inhaler in order to attach your sensor. Do not try to remove the battery from the sensor or service the sensor. The sensor is not a dose counter. Choking hazard; keep away from small children.
Place in therapy:
Complementary to current medication therapy
Propeller uses small sensors that attach to patients’ medication inhalers. The sensors are paired with a smartphone app to automatically track medication use and provide personal feedback and insights that help individuals and their doctors manage and reduce symptoms. Propeller data can be accessed by healthcare professionals through a portal or API.
A prescription is not required.
Depending on the program, patients enroll in Propeller on a Propeller website, in the Propeller app, or a similar enrollment process either directly or through a referral from their healthcare insurer, provider or pharmaceutical company. Once a patient has enrolled and signed in to the app, they are mailed a sensor to attach to their inhaler.
Use of the product requires access to:
Healthcare providers can use the Propeller Provider Portal to remotely monitor patients’ controller medication adherence and rescue medication usage as well as to receive notifications when patients are at increased risk of exacerbations.
Propeller is made available through grants and partnerships with payers, providers, and PBMs.
Propeller is available in:
Over 100,000 patients have signed up for Propeller, more than any other digital therapeutic in the respiratory space.